Determinants of virological outcome and adverse events in African children treated with paediatric nevirapine fixed-dose-combination tablets

Por BIENCZAK, Andrzej, DENTI, Paolo, Adrian, COOK, WIESNER, Lubbe, MULENGA, Veronica, KITYO, Cissy, KEKITIINWA, Addy, GIBB, Diana M., BURGER, David, WALKER, A. Sarah, MCILLERON, Helen
Publicado no AIDS (2017)

Plasma Efavirenz Exposure, Sex, and Age Predict Virological Response in HIV-Infected African Children

Por Bienczak, Andrzej, Denti, Paolo, Cook, Adrian, Wiesner, Lubbe, Mulenga, Veronica, Kityo, Cissy, Kekitiinwa, Addy, Gibb, Diana M., Burger, David, Walker, A. Sarah, McIlleron, Helen
Publicado no J Acquir Immune Defic Syndr (2016)

Effect of diurnal variation, CYP2B6 genotype and age on the pharmacokinetics of nevirapine in African children

Por Bienczak, Andrzej, Cook, Adrian, Wiesner, Lubbe, Mulenga, Veronica, Kityo, Cissy, Kekitiinwa, Addy, Walker, A. Sarah, Owen, Andrew, Gibb, Diana M., Burger, David, McIlleron, Helen, Denti, Paolo
Publicado no J Antimicrob Chemother (2017)

The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African children

Por Bienczak, Andrzej, Cook, Adrian, Wiesner, Lubbe, Olagunju, Adeniyi, Mulenga, Veronica, Kityo, Cissy, Kekitiinwa, Addy, Owen, Andrew, Walker, A. Sarah, Gibb, Diana M., McIlleron, Helen, Burger, David, Denti, Paolo
Publicado no Br J Clin Pharmacol (2016)